These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23675936)

  • 1. Understanding the molecular properties and metabolism of top prescribed drugs.
    Zhong HA; Mashinson V; Woolman TA; Zha M
    Curr Top Med Chem; 2013; 13(11):1290-307. PubMed ID: 23675936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016.
    Saravanakumar A; Sadighi A; Ryu R; Akhlaghi F
    Clin Pharmacokinet; 2019 Oct; 58(10):1281-1294. PubMed ID: 30972694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a set of simple, interpretable ADMET rules of thumb.
    Gleeson MP
    J Med Chem; 2008 Feb; 51(4):817-34. PubMed ID: 18232648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.
    Gleeson P; Bravi G; Modi S; Lowe D
    Bioorg Med Chem; 2009 Aug; 17(16):5906-19. PubMed ID: 19632124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs.
    Karami TK; Hailu S; Feng S; Graham R; Gukasyan HJ
    J Ocul Pharmacol Ther; 2022; 38(1):43-55. PubMed ID: 34905402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of reliable aqueous solubility models and their application in druglike analysis.
    Wang J; Krudy G; Hou T; Zhang W; Holland G; Xu X
    J Chem Inf Model; 2007; 47(4):1395-404. PubMed ID: 17569522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation.
    Guimarães CR; Mathiowetz AM; Shalaeva M; Goetz G; Liras S
    J Chem Inf Model; 2012 Apr; 52(4):882-90. PubMed ID: 22394163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of liposomal curcumin cytochrome p450 metabolism.
    Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    J Comput Aided Mol Des; 2002; 16(5-6):325-34. PubMed ID: 12489682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design.
    Estrada E
    Mini Rev Med Chem; 2008 Mar; 8(3):213-21. PubMed ID: 18336341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
    Möbitz H
    ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational prediction of octanol-water partition coefficient based on the extended solvent-contact model.
    Kim T; Park H
    J Mol Graph Model; 2015 Jul; 60():108-17. PubMed ID: 26142695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulation.
    Lu C; Suri A; Shyu WC; Prakash S
    Biopharm Drug Dispos; 2014 Dec; 35(9):543-52. PubMed ID: 25264242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.